These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15150704)

  • 21. Changes and predictors of radiation-induced oral mucositis in patients with oral cavity cancer during active treatment.
    Chen SC; Lai YH; Huang BS; Lin CY; Fan KH; Chang JT
    Eur J Oncol Nurs; 2015 Jun; 19(3):214-9. PubMed ID: 25586214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion (ADOPT) study.
    Kanagalingam J; Wahid MIA; Lin JC; Cupino NA; Liu E; Kang JH; Bazarbashi S; Bender Moreira N; Arumugam H; Mueller S; Moon H
    Support Care Cancer; 2018 Jul; 26(7):2191-2200. PubMed ID: 29387994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil.
    Nikoletti S; Hyde S; Shaw T; Myers H; Kristjanson LJ
    J Clin Nurs; 2005 Jul; 14(6):750-3. PubMed ID: 15946283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of adding the herb Achillea millefolium on mouthwash on chemotherapy induced oral mucositis in cancer patients: A double-blind randomized controlled trial.
    Miranzadeh S; Adib-Hajbaghery M; Soleymanpoor L; Ehsani M
    Eur J Oncol Nurs; 2015 Jun; 19(3):207-13. PubMed ID: 25667123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.
    Peterson DE; Barker NP; Akhmadullina LI; Rodionova I; Sherman NZ; Davidenko IS; Rakovskaya GN; Gotovkin EA; Shinkarev SA; Kopp MV; Kulikov EP; Moiseyenko VM; Gertner JM; Firsov I; Tuleneva T; Yarosh A; Woon CW
    J Clin Oncol; 2009 Sep; 27(26):4333-8. PubMed ID: 19636011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of severe oral mucositis in paediatric cancer patients: a prospective study.
    Otmani N; Alami R; Hessissen L; Mokhtari A; Soulaymani A; Khattab M
    Int J Paediatr Dent; 2011 May; 21(3):210-6. PubMed ID: 21362073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral mucositis: time for more studies.
    Alvarado Y; Bellm LA; Giles FJ
    Hematology; 2002 Oct; 7(5):281-9. PubMed ID: 12850815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing oral mucositis in patients receiving chemotherapy.
    Dodd MJ; Miaskowski C; Dibble SL; Paul SM; MacPhail L; Greenspan D; Shiba G
    Cancer Pract; 2000; 8(6):291-7. PubMed ID: 11898146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral mucositis: a phenomenological study of pediatric patients' and their parents' perspectives and experiences.
    Cheng KK
    Support Care Cancer; 2009 Jul; 17(7):829-37. PubMed ID: 19322593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of herpes simplex virus reactivation in chemotherapy-induced oral mucositis.
    Redding SW
    NCI Monogr; 1990; (9):103-5. PubMed ID: 2160612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant.
    Schuster MW; Shore TB; Harpel JG; Greenberg J; Jalilizeinali B; Possley S; Gerwien RW; Hahne W; Halvorsen YD
    Support Care Cancer; 2008 May; 16(5):477-83. PubMed ID: 17710442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for chemotherapy-induced oral mucositis: dental appliances, oral hygiene, previous oral lesions, and history of smoking.
    Dodd MJ; Miaskowski C; Shiba GH; Dibble SL; Greenspan D; MacPhail L; Paul SM; Larson P
    Cancer Invest; 1999; 17(4):278-84. PubMed ID: 10225008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
    Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
    Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation.
    Hayashi H; Kobayashi R; Suzuki A; Ishihara M; Nakamura N; Kitagawa J; Kanemura N; Kasahara S; Kitaichi K; Hara T; Tsurumi H; Moriwaki H; Itoh Y
    Anticancer Res; 2014 Dec; 34(12):7271-7. PubMed ID: 25503160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy induced oral mucositis: prevention is possible.
    Cidon EU
    Chin Clin Oncol; 2018 Feb; 7(1):6. PubMed ID: 29156889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children.
    Kuhn A; Porto FA; Miraglia P; Brunetto AL
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):33-7. PubMed ID: 19125084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of methods to determine the prevalence and nature of oral mucositis.
    Dodd MJ; Facione NC; Dibble SL; MacPhail L
    Cancer Pract; 1996; 4(6):312-8. PubMed ID: 9128483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life.
    Cheng KK; Leung SF; Liang RH; Tai JW; Yeung RM; Thompson DR
    Support Care Cancer; 2010 Nov; 18(11):1477-85. PubMed ID: 19916030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    Support Care Cancer; 2007 May; 15(5):491-6. PubMed ID: 17139495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy.
    Adamietz IA; Rahn R; Böttcher HD; Schäfer V; Reimer K; Fleischer W
    Support Care Cancer; 1998 Jul; 6(4):373-7. PubMed ID: 9695205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.